Email Updates

Search form

You are here

AVAC in the News

  • The rollout of oral HIV pre-exposure prophylaxis (PrEP), a pill that prevents infection when taken daily, is not being managed well in parts of Africa.

    November 14, 2018
    Africa Portal
  • HIV prevention research funding continued to decline in 2017 for the fifth consecutive year, driven largely by a five-year low in US public sector funding, according to a report released on Thursday at the HIV Research for Prevention conference in Madrid, Spain.

    October 27, 2018
  • The ability of the HIV virus to mutate all the time is proving to be the most outstanding stumbling block for scientists to get the much-awaited HIV cure, researcher Dr Zaza Ndhlovu, Africa Health Research Institute, South Africa has said.

    October 26, 2018
    The Observer
  • As the world all over is looking forward to a day when scientists will announce that finally there’s a permanent HIV and AIDS cure, scientists at the HIV Research for Prevention Conference-HIVR4P- in Madrid, Spain, present evidence that shows how difficult it is to get a permanent HIV cure at the moment.

    October 25, 2018
  • Many more gay men and men who have sex with men (MSM) may be using pre-exposure prophylaxis (PrEP) than figures from demonstration projects and national rollouts suggest, Michelle Rodolph, technical officer for the World Health Organization, told the HIVR4P 2018 conference in Madrid in Spain.

    October 24, 2018
  • "It is not just about R&D but about R&D and D — research and development, and delivery. If you take anyone of those three letters out, we fail. Each of them is equally important."

    October 24, 2018
    Citizen News Service
  • At least 309,525 people have started to take pre-exposure prophylaxis (PrEP) in 68 countries, but 71 percent of PrEP users are in North America, according to a global analysis presented to the HIVR4P conference in Madrid.

    October 23, 2018
  • Just before Tony Fauci, M.D., director of the NIH's National Institute of Allergies and Infectious Diseases (NIAID) took the stage to deliver his address to the crowd, several dozen people filed on the stage with signs that read: "Whose choice, our choice?" and "Dear NIAID, Fund Microbicides NOW!"

    October 23, 2018
    The Body
  • The third HIV Research for Prevention conference (HIVR4P) in Madrid next week (21 to 25 October) will feature news from every aspect of HIV prevention. HIVR4P came from a merger between the HIV vaccine and HIV microbicides conferences, and the breadth of its coverage reflects this.

    October 18, 2018
  • Recent data from the National AIDS Control Organisation shows that the number of new HIV cases in India has fallen significantly since the peak of the epidemic in India in 2005. However, the pace of decline has also slowed in recent years.

    September 27, 2018